Investment Rating - The report maintains a "B" rating for the new materials sector, indicating a leading performance compared to the market [1]. Core Insights - The new materials sector has shown resilience, with the new materials index rising by 0.86%, outperforming the ChiNext index by 2.54% during the week [3]. - The vitamin sector is experiencing a price surge due to geopolitical tensions in the Middle East, particularly affecting the Hormuz Strait, which has led to increased costs across the petrochemical supply chain [5]. - Key vitamin products such as Vitamin A and E have seen significant price increases, with Vitamin A reaching 110,000 CNY/ton (up 15.79% week-on-week) and Vitamin E at 101,000 CNY/ton (up 18.82% week-on-week) [5]. Summary by Sections Market Performance - The new materials sector has outperformed the broader market indices, with specific segments like battery chemicals rising by 10.69% and industrial gases by 1.78% [3][12]. - Over the past five trading days, the synthetic biology index fell by 0.92%, while semiconductor materials dropped by 2.80% [3][16]. Price Tracking - Amino acids have shown stable prices, with valine at 14,550 CNY/ton and arginine at 23,250 CNY/ton [4]. - The price of Vitamin A has increased significantly, reflecting a broader trend of rising prices in the vitamin sector due to supply constraints [4][5]. Investment Recommendations - The report suggests focusing on companies within the vitamin supply chain, such as New Hope Liuhe, Andisoo, Meihua Biological, and Zhejiang Medicine, as they are expected to benefit from the ongoing price increases [5][6].

Core Viewpoint - The article emphasizes the rising importance of biomanufacturing as a strategic and innovative sector, which is seen as a new growth point that can drive industrial structure optimization and economic model transformation. The release of the "2025 China Synthetic Biomanufacturing Industry Development White Paper" highlights the current state, trends, and challenges of the biomanufacturing industry in China [1]. Group 1: Current State and Trends - The white paper provides an overview of the development status and trends of biomanufacturing, analyzing the industry chain and key application directions [1]. - It compares the competitive landscape of biomanufacturing between China and the United States, identifying key differences and opportunities [7]. - Future development trends in biomanufacturing are discussed, indicating potential areas for growth and innovation [7]. Group 2: Policy Landscape - The report outlines major domestic and international policies affecting the biomanufacturing sector for 2024-2025, providing insights into regulatory environments [7]. - It details foreign policies that influence the global biomanufacturing industry, as well as domestic policies that shape the Chinese market [7]. Group 3: Industry Mapping and Key Players - The white paper identifies the "10 Leading Enterprises" in China's biomanufacturing industry, showcasing significant players and their contributions [7]. - It lists 15 publicly listed companies involved in synthetic biology, summarizing their strategic directions and investments in the field [7]. - The report highlights 20 popular products in the biomanufacturing space, linking them to corresponding companies [7]. Group 4: Challenges and Recommendations - The document discusses the challenges faced by China's biomanufacturing industry, including technological, regulatory, and market-related issues [7]. - It offers targeted policy recommendations to address these challenges, aiming to support the sustainable development of the biomanufacturing sector [7].

- The report focuses on the investment value of the CSI All Index Agriculture, Forestry, Animal Husbandry, and Fishery Index (930910.CSI), which is a secondary industry index under the CSI All Index series, reflecting the overall performance of the agriculture sector in the A-share market[39][40][42] - The index adopts a fully replicated method to construct the investment portfolio, aiming to minimize tracking deviation and annualized tracking error, with a target of absolute daily tracking deviation not exceeding 0.2% and annualized tracking error not exceeding 2%[9][89] - The index's sample adjustment rules include semi-annual adjustments implemented on the next trading day after the second Friday of June and December each year, and temporary adjustments in special circumstances such as delisting or corporate restructuring[41][45] - The weighting and weight rules use adjusted market capitalization weighting, with a single stock weight cap of 15%, and the top two weighted stocks are highly concentrated[46][47] - The index's industry distribution is characterized by "core focus and diversified collaboration," with a significant tilt towards two popular sub-sectors: pig farming (47.41%) and seed planting (15.52%), reflecting the core value and investment potential of these sectors[51][52] - The index demonstrates strong cyclical attributes, with a long-term annualized return exceeding 12% over the past 20 years, significantly outperforming broader indices like the Shanghai Composite Index and CSI 300[67][68] - The agriculture sector's valuation is currently in a low-to-neutral range, with a PE-TTM of 24.56x as of March 2026, corresponding to a historical percentile of 27.06%, providing a certain safety margin[76][85]

Group 1 - Wanhua Chemical (600309) is a global leader in the polyurethane industry, with core businesses covering MDI, TDI, and polyether polyols, while also extending into petrochemicals, new materials, and fine chemicals. The company has established a comprehensive industrial chain from raw materials to end products, maintaining a leading market share in MDI due to its scale and technological barriers. It is expanding into high-performance materials and new energy materials, aligning with the trends in new energy and high-end manufacturing, which opens up long-term growth opportunities [1][25] - Juhua Co., Ltd. (600160) is a leading enterprise in the domestic fluorochemical sector, with core businesses including fluorochemicals, chlor-alkali chemicals, and petrochemical materials. The company has a significant capacity in fluorinated refrigerants and is expanding into electronic chemicals and photovoltaic fluorinated materials, gradually breaking through overseas technological monopolies. Its comprehensive layout in the fluorochemical industry chain and strong compliance and cost advantages position it well for growth [2][26] - Satellite Chemical (002648) is a leader in the domestic acrylic acid and ester industry, focusing on acrylic acid, high polymer emulsions, and functional polymer materials. The company is accelerating its layout in photovoltaic-grade EVA and POE new energy materials, leveraging its propane dehydrogenation process to build an integrated industrial chain. Its strong cost control and alignment with the growth of the photovoltaic and lithium battery industries provide sustainable development momentum [3][27] Group 2 - Hoshine Silicon Industry (603260) is a global leader in industrial silicon and organic silicon, with core businesses covering industrial silicon, organic silicon, and graphite electrodes. The company has a leading production capacity in industrial silicon and a comprehensive product range in organic silicon, benefiting from energy-rich production bases. Its complete industrial chain layout and focus on high-purity silicon for photovoltaics align with trends in new energy and high-end manufacturing, offering significant long-term growth potential [4][28] - Adisseo (600299) is a global leader in animal nutrition additives, with core products including methionine and vitamins widely used in livestock farming. The company has established a stable supply system and significant technological and cost advantages, while also expanding into biotechnology and functional food sectors. Its stable performance and low sensitivity to macroeconomic fluctuations enhance its competitive position in the global feed additive industry [5][29] - Zhejiang Longsheng (600352) is a global leader in the dye industry, with core businesses covering dyes, intermediates, and water-reducing agents. The company has a leading market share in disperse and reactive dyes, supported by an integrated industrial chain and strong cost control. Its diversified business structure enhances risk resilience, while its expansion into hydrogen energy and environmental protection projects strengthens its competitive position in the global dye and fine chemical industry [6][30] Group 3 - Haohua Technology (600378) is a domestic leader in high-end fluorinated materials and electronic chemicals, with core businesses including fluororesins, fluororubbers, and electronic-grade chemicals. The company benefits from deep technological reserves and has achieved some degree of import substitution. Its focus on high-end chemical materials aligns with national strategic emerging industries, providing long-term growth support [7][31] - Sanmei Co., Ltd. (603379) is a key player in the domestic fluorochemical sector, focusing on refrigerants, foaming agents, and fluorinated salts. The company has established an integrated fluorochemical industrial chain and is expanding into environmentally friendly refrigerants. Its stable cash flow and strong downstream demand support its competitive position in the domestic fluorochemical market [8][32] - Meihua Biological (600873) is a global leader in the amino acid industry, with core products including monosodium glutamate and amino acids widely used in food, feed, and pharmaceuticals. The company has a leading market share in MSG and lysine, supported by its advanced fermentation technology and cost advantages. Its expansion into pharmaceutical-grade amino acids and biodegradable materials enhances its competitive position in the global amino acid and fermentation industry [9][33]

1. Report Industry Investment Rating - Not provided in the given content 2. Core Views of the Report - The agriculture, livestock, and fishery sector is at the intersection of cycle repair, policy strengthening, and price re - evaluation, with clear investment opportunities [1][11]. - The pig - breeding industry is approaching the critical point of accelerated capacity clearance, and the feed industry has cost improvement and post - cycle repair attributes. The planting chain and seed industry have strategic allocation value [2][3]. - The CSI All - China Agriculture, Livestock, and Fishery Index focuses on investment opportunities in the A - share agricultural sector, with high elasticity and stable improvement in the operating ability of its constituent stocks [4]. - The JingShun Agriculture, Livestock, and Fishery ETF (560210) provides a convenient investment tool for investors to share the growth of the agriculture, livestock, and fishery industry at a low cost [5] 3. Summary by Relevant Catalogs 3.1. Agriculture, Livestock, and Fishery Sector Investment Opportunities - **Pig - breeding**: The pig - breeding industry is at the critical point of accelerated capacity clearance. Low prices, losses, and capacity reduction are forming a linkage with subsequent price increase expectations. The profit elasticity of the sector is usually higher than the increase in pig prices, and it can drive the prosperity of the entire agricultural industry chain [17][21][26]. - **Feed industry**: It has cost improvement and post - cycle repair attributes. It is a core intermediate link in the agricultural industry chain, with a clear trend of concentration among leading enterprises. It has asset allocation value and can connect the planting and breeding industries [27][29][30]. - **Planting chain and seed industry**: They are long - term investment mainlines in the agricultural sector. Policy support is strong, and the grain output and related indicators are improving. The seed industry is in the stage of inventory digestion and system upgrading, and is expected to move towards high - quality development [31][32][39]. - **Valuation and investment value**: The current overall valuation of the agricultural sector is at a relatively low level in history, providing a solid safety margin for subsequent valuation repair. The sector has multiple advantages such as left - side cycle layout, medium - term policy catalysis, and marginal price increase expectations [12][16][41] 3.2. CSI All - China Agriculture, Livestock, and Fishery Index - **Index composition**: It selects stocks of listed companies in the agriculture, livestock, and fishery industry from the CSI All - China Index, with a semi - annual adjustment. The weight of a single sample does not exceed 15% [43][45]. - **Index performance**: From 2005 to March 13, 2026, the cumulative increase of the index was 962.54%, significantly outperforming the CSI 300, which increased by 366.91% during the same period [44]. - **Industry focus**: It focuses on the "pig - breeding" and "seed" industries, with the main industries including aquaculture, planting, feed, chemical products, and animal health, with weights of 47.41%, 15.52%, 14.86%, 8.02%, and 7.03% respectively [48]. - **Market - value style**: It is positioned as a small - and medium - cap growth style. The average and median total market values of the index are 171 billion yuan and 70 billion yuan respectively. The operating ability of the constituent stocks has been steadily improving, and the total operating income has increased from 621.8 billion yuan in 2020 to 893.3 billion yuan in 2024 [51][52]. - **Weighted stocks**: The top 5 weighted stocks are Muyuan Co., Ltd., Wens Foodstuff Group Co., Ltd., Haid Group Co., Ltd., Zhengbang Technology Co., Ltd., and Meihua Biotech Group Co., Ltd., with a total weight of 44.03% for the top 5 and 57.46% for the top 10 [53] 3.3. JingShun Agriculture, Livestock, and Fishery ETF (560210) - **Product information**: It was established on March 11, 2026, with an establishment scale of 781 million yuan, and will be listed on March 20, 2026. It closely tracks the CSI All - China Agriculture, Livestock, and Fishery Index, and the assets invested in the constituent stocks and alternative constituent stocks of the target index are not less than 90% of the net asset value of the fund and not less than 80% of the non - cash fund assets [59]. - **Fund manager**: The fund manager is Gong Lili, who has 15 years of experience in the securities and fund industries and currently manages 11 fund products (excluding linked funds) with a total scale of 21 billion yuan [64]

证券代码：600873 证券简称：梅花生物 公告编号：2026-009 变更后企业法人营业执照的具体内容如下： 名称：梅花生物科技集团股份有限公司 统一社会信用代码：91540000219667563J 类型：其他股份有限公司（上市） 梅花生物科技集团股份有限公司 关于完成工商变更登记并换发营业执照的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 梅花生物科技集团股份有限公司（以下简称"公司"）分别于 2025 年 12 月 11 日和 2025 年 12 月 29 日召开了第十届董事会第二十三次会议和 2025 年第二 次临时股东大会，会上审议通过了《关于变更注册资本的议案》，具体内容详见 公司在上海证券交易所网站（http://www.sse.com.cn）上披露的相关公告。 2026 年 3 月 18 日，公司完成了相关工商变更登记手续，并取得了由西藏自 治区市场监督管理局换发的《营业执照》，公司注册资本已变更为 2,804,241,650 元。 成立日期：1995 年 02 月 09 日 1 住所：拉萨市金珠西路 ...

Group 1 - The article highlights that Chinese assets are attracting significant attention from overseas investors, particularly in the context of increased global market volatility and geopolitical risks, due to their unique "cost-performance" advantage [1][12]. - Recent data shows that South Korean investors have net bought A-share securities, including major companies like Sany Heavy Industry, China Power Construction, and Ganfeng Lithium, with net purchases exceeding $1 million for each [1][3]. - The "HALO" assets, which are traditional industrial leaders, are favored by South Korean investors as they are seen as having low replacement risk and are essential for infrastructure in energy transition and high-end manufacturing [4][5]. Group 2 - South Korean investors have shown strong interest in China's "HALO" assets and emerging sectors like semiconductors, with significant net purchases recorded for companies such as Sany Heavy Industry (over $630,000), China Power Construction (over $440,000), and XJ Electric (over $1.3 million) [3][4]. - The semiconductor sector has also attracted attention, with net purchases for leading companies like JCET Group and Accelink Technologies exceeding $150,000 [6]. - The investment environment for South Korean investors has improved, with a stable RMB exchange rate enhancing the attractiveness of Chinese assets [7]. Group 3 - The article discusses the increasing use of ETFs by overseas investors to access quality A-share assets, with notable net purchases in semiconductor ETFs [9][10]. - The two leading ETFs focused on robotics, Tiger China Humanoid Robot ETF and Kodex China Humanoid Robot ETF, are gaining traction among South Korean investors, providing a diversified investment approach [9]. - ETFs lower the barriers for foreign investors by simplifying the investment process and reducing transaction costs, making it easier to invest in Chinese high-tech sectors [10]. Group 4 - The article emphasizes that despite some recovery in A-shares and Hong Kong stocks, the valuation of major indices remains low, while sectors like technology and manufacturing are expected to see strong profit growth by 2026 [12]. - The comprehensive advantages of China's AI and robotics sectors, supported by clear industrial policies, make them attractive for long-term investment [12]. - The article concludes that the Chinese capital market is becoming a preferred choice for global investors seeking quality assets, especially in the context of a weak dollar and low correlation with international geopolitical risks [12].

Investment Rating - The report maintains a "B" rating for the new materials sector, indicating a leading position in the market [2]. Core Insights - The new materials sector has experienced a decline, with the new materials index dropping by 5.28%, underperforming the ChiNext index by 2.83% [3][12]. - The ongoing geopolitical tensions in the Middle East, particularly the disruption of commercial shipping in the Strait of Hormuz, have created opportunities in the vitamin and amino acid industries due to supply shortages and rising prices [5]. - Key products such as Vitamin E and methionine have shown significant price increases, with Vitamin E reaching 66,500 CNY/ton (up 11.8% week-on-week) and methionine at 23,850 CNY/ton (up 24.54% week-on-week) [5]. Summary by Sections 1. Market Performance - The new materials sector has seen a downturn, with various sub-sectors such as semiconductor materials and electronic chemicals experiencing declines of 9.92% and 7.39% respectively over the past five trading days [3][16]. - The overall performance of the basic chemicals and new materials sectors has been negative, with the Shanghai Composite Index and ChiNext Index also showing declines [12]. 2. Price Tracking - Amino acids: Valine at 13,400 CNY/ton (-0.74%), arginine at 22,000 CNY/ton (unchanged), tryptophan at 33,000 CNY/ton (+0.46%), and methionine at 23,850 CNY/ton (+24.54%) [4]. - Vitamins: Vitamin A at 60,500 CNY/ton (unchanged), Vitamin E at 66,500 CNY/ton (+11.76%), and Vitamin D3 at 192,500 CNY/ton (unchanged) [4]. - Industrial gases: UPSSS grade hydrofluoric acid at 11,000 CNY/ton (unchanged) and EL grade hydrofluoric acid at 6,385 CNY/ton (unchanged) [4]. 3. Investment Recommendations - The report suggests focusing on companies within the vitamin and amino acid supply chains, particularly due to the current market dynamics influenced by geopolitical factors [5]. - Recommended companies include Xinhecheng, Andisu, Meihua Biological, and Zhejiang Medicine, which are expected to benefit from the rising prices of core products [5].

Investment Rating - The report maintains an "Overweight" rating for the basic chemicals and oil and gas sectors [6]. Core Insights - The geopolitical tensions, particularly in the Middle East, have led to concerns over global oil and gas supply, prompting a price surge in energy and chemical products. The Brent crude oil price forecast for 2026 has been raised to $78 per barrel, with a potential extreme scenario of $95 per barrel if production facilities are severely impacted [1][2][9]. - China's energy and chemical supply chain is relatively resilient, with domestic supply disruptions expected to be less severe than those faced by overseas companies. This stability is anticipated to support a recovery in the chemical industry as global inventory replenishment occurs [1][3]. - The report highlights potential benefits for domestic amino acid companies and overseas urea producers due to rising international grain prices, recommending companies like Meihua Biological [1][3]. - Emerging demand for alternative products such as renewable energy storage, green hydrogen, and biomanufacturing is expected to create long-term growth opportunities, with recommendations for upstream phosphate chemical companies like Yuntianhua and Chuanheng [1]. Summary by Sections Oil and Gas Sector - The report indicates that the oil market is experiencing a risk premium and a global strategic inventory correction, with the Brent crude price forecast adjusted to $78 per barrel for 2026. The oil and gas extraction sectors, particularly coal-to-olefins, are expected to benefit from this situation [1][2]. - The report notes that the Middle East's oil exports through the Strait of Hormuz account for a significant portion of global trade, and ongoing geopolitical tensions could lead to production halts in the region [2][9]. Chemical Industry - China's chemical supply chain is described as robust, with significant domestic production capabilities. The report cites that in 2025, China's crude oil production, imports, and refinery processing volumes were 220 million tons, 580 million tons, and 740 million tons, respectively [3][22]. - The report emphasizes that domestic companies are likely to benefit from rising prices of MDI, methionine, and vitamin E due to supply disruptions in overseas markets [4][48]. Agricultural Chemicals - The report highlights a global tightening of urea and sulfur supplies, with international urea prices rising significantly due to geopolitical tensions. The Southeast Asian CFR urea price reached $510 per ton, reflecting a 23% increase since early 2026 [5][56]. - Recommendations include focusing on companies involved in the sulfur and fertilizer sectors, as they are expected to benefit from the current supply constraints [56].

Investment Rating - The report maintains a "Recommended" rating for the chemical industry [1][28]. Core Insights - The global chemical industry is entering a significant upward cycle driven by anti-involution and AI demand, with China's leading companies benefiting from solid cost and efficiency advantages. The industry is expected to see a substantial increase in free cash flow as capacity expansion slows, transforming companies from cash-consuming entities to cash-generating ones. The upcoming peak season for chemicals is anticipated to enhance profitability, making it crucial to focus on demand, value, and supply dynamics for investment opportunities [3][28]. Summary by Sections Recent Trends - As of March 5, 2026, the Guohai Chemical Prosperity Index stands at 99.35, reflecting a 5.16 increase from February 26, 2026 [1]. Performance Metrics - The basic chemical sector has shown a performance increase of 7.4% over the past month, 23.6% over the past three months, and 50.8% over the past year [4]. Investment Opportunities 1. **Value-Driven Opportunities**: Potential for increased dividend yields in sectors such as coal chemicals (e.g., Hualu Hengsheng, Luxi Chemical), oil refining (e.g., Hengli Petrochemical, Sinopec), pesticides (e.g., Yangnong Chemical), and potassium fertilizers (e.g., Salt Lake Industry) [3]. 2. **Supply-Driven Opportunities**: Focus on domestic anti-involution policies and European capacity exits, with key players including PTA/Polyester (e.g., Xinfengming, Tongkun), glyphosate and organosilicon (e.g., Xingfa Group), and industrial silicon (e.g., Hoshine Silicon) [6]. 3. **Demand-Driven Opportunities**: Highlighting sectors benefiting from large-scale opportunities, including gas turbines (e.g., Zhenhua Group), refrigerants (e.g., Juhua), and energy storage (e.g., Chuanheng) [6]. Key Companies and Earnings Forecasts - The report tracks several key companies with their respective earnings per share (EPS) forecasts for 2024 to 2026, indicating a positive outlook for many, including Dongfang Shenghong, Hubei Yihua, and Wanhua Chemical [29]. Market Observations - The report notes that geopolitical tensions, particularly in the Middle East, are likely to drive oil prices higher, benefiting companies like China National Petroleum and CNOOC, while also increasing costs for petrochemical products [9][13]. Price Trends - Recent price increases have been observed in various chemical products, including MDI and TDI, with significant upward movements in raw material costs due to geopolitical events [14][18]. Conclusion - The chemical industry is positioned for a favorable outlook, driven by structural changes in supply and demand dynamics, with a focus on companies that can leverage these trends for growth and profitability [28].